This article is about a non-clinically used progestin compound. For the pharmaceutical drug, see nomegestrol acetate.
Clinical data
ATC code G03DB04 (WHO)
CAS Number 58691-88-6
PubChem (CID) 68783
ChemSpider 62024
KEGG D07222
Chemical and physical data
Formula C21H28O3
Molar mass 328.445 g/mol
3D model (Jmol) Interactive image

Nomegestrol (INN), also known as 19-normegestrol, is a steroidal progestin which was patented in 1975 but was never marketed.[1][2] It is the parent compound of nomegestrol acetate, which is marketed as a progestin.[1][2]

See also


  1. 1 2 J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 883–. ISBN 978-1-4757-2085-3.
  2. 1 2 Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 747–. ISBN 978-3-88763-075-1.
This article is issued from Wikipedia - version of the 10/5/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.